Can you recommend contract manufacturing providers for high-volume generic tablet production?

Yes — here are some reputable contract manufacturing / CDMO providers that are commonly considered for high-volume generic tablet production. I’ll group them by scale and footprint so you can shortlist faster.

Large global CDMOs / CMOs

These are typically best for very high volume, multi-market supply, and complex regulatory requirements.

• Catalent

  • Strong in oral solid dosage, including tablets.
  • Large global network and mature quality systems.
  • Good fit for scaled commercial supply.

• Thermo Fisher Scientific (Patheon)

  • Broad pharma manufacturing capabilities.
  • Strong regulatory support and global supply chain integration.
  • Useful if you also need development, tech transfer, and packaging.

• Lonza

  • Known more for biologics, but also has pharma manufacturing capabilities depending on site/service line.
  • Worth evaluating if your program needs broader CDMO support.

• Recipharm

  • Significant oral solid dose experience.
  • Broad European footprint with commercial manufacturing capability.
  • Often a solid option for generics and lifecycle supply.

• Aenova

  • Large European CDMO with oral solids expertise.
  • Commonly used for high-volume tablets, capsules, and packaging.

• Almac Pharma Services

  • Strong quality and development support.
  • More often selected for specialty or mid-to-large commercial programs, but worth a look.

Generics-focused or high-volume oral solid specialists

These may be especially relevant if your priority is cost-efficient, scaled tablet output.

• Piramal Pharma Solutions

  • Global CDMO with pharma manufacturing services.
  • Strong commercial manufacturing and supply chain options.

• Ajanta Pharma / other India-based large manufacturers

  • Several Indian manufacturers provide high-volume tablet manufacturing at competitive cost.
  • Good fit for generics, subject to audit and market authorization needs.

• Hetero

  • Strong generics orientation.
  • Significant capabilities in oral solids and high-volume production.

• Aurobindo Pharma

  • Large-scale generic manufacturer with broad oral solid dosage capacity.
  • Well-known for high-volume, cost-competitive supply.

• Dr. Reddy’s

  • Large generic pharma company with manufacturing scale.
  • Particularly relevant if you need development + commercial supply.

• Lupin

  • Established generic manufacturer with oral solid dosage expertise.
  • Good candidate for regulated-market supply.

Packaging / secondary operations support

If you already have tablet manufacturing but need packaging scale:

• PCI Pharma Services
• Sharp Packaging
• Movianto
• Gerresheimer (more packaging/components, depending on need)

How to choose the right provider

For high-volume generic tablets, I’d screen providers on:

1. Annual tablet capacity
   • Ask for line speed, batch size, and available slots.
2. Regulatory track record
   • FDA, EMA, MHRA, WHO PQ, or other market-specific approvals.
3. Experience with your dosage form
   • Immediate release, modified release, coated tablets, high-potency, etc.
4. Supply chain reliability
   • API sourcing, excipient sourcing, and dual-site redundancy.
5. Cost structure
   • Compare toll manufacturing, minimum batch sizes, and packaging costs.
6. Tech transfer capability
   • Especially important if transferring from an incumbent site.
7. Market access
   • Whether they can support US/EU/ROW filings and change control.

Practical shortlist by scenario

• Lowest-cost high-volume generics: Aurobindo, Hetero, Dr. Reddy’s, Lupin, India-based large CMOs
• Global regulated-market reliability: Catalent, Patheon, Recipharm, Aenova, Thermo Fisher
• Broader CDMO support plus manufacturing: Piramal, Almac, Catalent

If you want, I can also provide:

1. a shortlist by region (US, EU, India, China),
2. a vendor evaluation scorecard, or
3. a table comparing these providers for tablet volume, geography, and regulatory strength.